Non-Hodgkin lymphoma therapy landscape

被引:0
|
作者
Kritika Chaudhari
Salman Rizvi
Basharut A. Syed
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:663 / 664
页数:1
相关论文
共 50 条
  • [21] Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy
    Santo, Ana Espirito
    Medeiros, Rui
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1625 - 1634
  • [22] Monoclonal Antibody Therapy and Non-Hodgkin's Lymphoma
    Marignani, Massimo
    Angeletti, Stefano
    delle Fave, Gianfranco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02): : 192 - 193
  • [23] Molecular pathogenesis in non-Hodgkin lymphoma: Implications for therapy
    Vose, Julie M.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 155 - 156
  • [24] Rituximab therapy for indolent non-Hodgkin's lymphoma
    Hagenbeek, A
    Czuczman, MS
    Ghielmini, M
    Herold, M
    Kimby, E
    Solal-Céligny, P
    Unterhalt, M
    [J]. ANTI-CANCER DRUGS, 2002, 13 : S11 - S17
  • [25] Therapy strategies for aggressive non-Hodgkin's lymphoma
    Held, G.
    Wulf, G.
    [J]. ONKOLOGE, 2015, 21 (10): : 946 - 952
  • [26] Rituximab: An innovative therapy for non-Hodgkin's lymphoma
    Wood, AM
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (03) : 215 - 229
  • [27] Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma
    Weiss, Robert F.
    Miller, Merlin G.
    Cronin, John F.
    Hensley, Harvey H.
    Joshi, Indira D.
    Smith, Mitchell R.
    [J]. PLOS ONE, 2012, 7 (12):
  • [28] Intensive therapy for non-Hodgkin lymphoma: indications and modalities
    Albin, N
    Bemba, M
    Gabarre, J
    Sutton, L
    Leblond, V
    [J]. PRESSE MEDICALE, 1998, 27 (20): : 977 - 985
  • [29] Non-Hodgkin's lymphoma after immunosuppressive therapy
    Kinlen, LJ
    [J]. GUT, 2000, 47 (04) : 462 - 463
  • [30] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
    Bei Hu
    Ryan Jacobs
    Nilanjan Ghosh
    [J]. Current Hematologic Malignancy Reports, 2018, 13 : 543 - 554